[
  {
    "title": "双成药业(002693.SZ)：部分董事、高管拟合计减持不超97.75万股",
    "href": "http://stock.jrj.com.cn/2022/12/09163937201740.shtml",
    "datetime": "2022-12-09 16:39:47",
    "code": "002693"
  },
  {
    "title": "A股异动 | 双成药业(002693.SZ)跌5% 5名董事、高管减持期届满 已合计减持107万股",
    "href": "http://stock.jrj.com.cn/2022/12/09143137201260.shtml",
    "datetime": "2022-12-09 14:31:10",
    "code": "002693"
  },
  {
    "title": "双成药业5名股东合计减持107万股 套现约636.65万 2022年前三季度公司亏损362.03万",
    "href": "http://stock.jrj.com.cn/2022/12/08191137199214.shtml",
    "datetime": "2022-12-08 19:11:57",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：5名董事、高管减持期届满 已合计减持107万股",
    "href": "http://stock.jrj.com.cn/2022/12/08171737198667.shtml",
    "datetime": "2022-12-08 17:17:45",
    "code": "002693"
  },
  {
    "title": "双成药业：收到与收益相关政府补助合计256.72万元",
    "href": "http://stock.jrj.com.cn/2022/12/02175537185362.shtml",
    "datetime": "2022-12-02 17:55:37",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)及子公司累计收到政府补助256.72万元",
    "href": "http://stock.jrj.com.cn/2022/12/02162837184618.shtml",
    "datetime": "2022-12-02 16:28:40",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：宁波双成取得换发的《药品生产许可证》",
    "href": "http://stock.jrj.com.cn/2022/11/16162737143712.shtml",
    "datetime": "2022-11-16 16:27:54",
    "code": "002693"
  },
  {
    "title": "【龙虎榜】双成药业11月10日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/10180437128285.shtml",
    "datetime": "2022-11-10 18:04:23",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：控股股东方面拟合计减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2022/11/09190837125023.shtml",
    "datetime": "2022-11-09 19:08:48",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：部分董事、高管已合计减持102万股",
    "href": "http://stock.jrj.com.cn/2022/11/08191337121541.shtml",
    "datetime": "2022-11-08 19:13:43",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：控股股东近日大宗交易减持300万股",
    "href": "http://stock.jrj.com.cn/2022/11/08190537121466.shtml",
    "datetime": "2022-11-08 19:05:58",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：第三季度净亏损180.65万元",
    "href": "http://stock.jrj.com.cn/2022/10/27165737089960.shtml",
    "datetime": "2022-10-27 16:57:02",
    "code": "002693"
  },
  {
    "title": "【龙虎榜】双成药业10月20日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/10/20180337070694.shtml",
    "datetime": "2022-10-20 18:03:54",
    "code": "002693"
  },
  {
    "title": "双成药业5连板，已收到HKF支付的部分里程碑款项",
    "href": "http://stock.jrj.com.cn/2022/10/19113937066295.shtml",
    "datetime": "2022-10-19 11:39:19",
    "code": "002693"
  },
  {
    "title": "【龙虎榜】双成药业10月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/10/17180337061144.shtml",
    "datetime": "2022-10-17 18:03:52",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：收到HKF支付的部分里程碑款项50万美元",
    "href": "http://stock.jrj.com.cn/2022/10/13164937053069.shtml",
    "datetime": "2022-10-13 16:49:40",
    "code": "002693"
  },
  {
    "title": "【龙虎榜】双成药业9月30日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/09/30180437034649.shtml",
    "datetime": "2022-09-30 18:04:20",
    "code": "002693"
  },
  {
    "title": "【龙虎榜】双成药业9月28日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/09/28180337028178.shtml",
    "datetime": "2022-09-28 18:03:33",
    "code": "002693"
  },
  {
    "title": "A股异动 | 双成药业(002693.SZ)两连板，与Meitheal、HKF签许可及供应协议",
    "href": "http://stock.jrj.com.cn/2022/09/27101037023900.shtml",
    "datetime": "2022-09-27 10:10:57",
    "code": "002693"
  },
  {
    "title": "A股异动 | 双成药业一字板 将注射用紫杉醇在美国的独家经销权许可授予Meitheal和HKF",
    "href": "http://stock.jrj.com.cn/2022/09/26095037020394.shtml",
    "datetime": "2022-09-26 09:50:22",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：将注射用紫杉醇(白蛋白结合型)在美国的独家经销权许可授予Meitheal和HKF",
    "href": "http://stock.jrj.com.cn/2022/09/25181837019534.shtml",
    "datetime": "2022-09-25 18:18:13",
    "code": "002693"
  },
  {
    "title": "双成药业：双成投资所持2150万股被质押 占公司总股本比例5.18%",
    "href": "http://stock.jrj.com.cn/2022/09/14173436994598.shtml",
    "datetime": "2022-09-14 17:34:26",
    "code": "002693"
  },
  {
    "title": "【龙虎榜】双成药业9月8日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/09/08180436983869.shtml",
    "datetime": "2022-09-08 18:04:22",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：部分董事、高管减持期过半未减持",
    "href": "http://stock.jrj.com.cn/2022/09/07165636980451.shtml",
    "datetime": "2022-09-07 16:56:59",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)上半年净亏损181.38万元 同比转亏",
    "href": "http://stock.jrj.com.cn/2022/08/30160136952745.shtml",
    "datetime": "2022-08-30 16:01:49",
    "code": "002693"
  },
  {
    "title": "双成药业：醋酸曲普瑞林注射液获国家药监局注册批件",
    "href": "http://stock.jrj.com.cn/2022/08/14182436897888.shtml",
    "datetime": "2022-08-14 18:24:26",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：醋酸曲普瑞林注射液获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2022/08/14164136897808.shtml",
    "datetime": "2022-08-14 16:41:38",
    "code": "002693"
  },
  {
    "title": "双成药业2022年上半年亏损181.38万同比由盈转亏 药品销售受集采降价",
    "href": "http://stock.jrj.com.cn/2022/08/12185036896108.shtml",
    "datetime": "2022-08-12 18:50:24",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：拟将拥有的醋酸曲普瑞林注射液相关权利转让予莱美药业",
    "href": "http://stock.jrj.com.cn/2022/08/01200536860504.shtml",
    "datetime": "2022-08-01 20:05:22",
    "code": "002693"
  },
  {
    "title": "双成药业：拟3200万元转让醋酸曲普瑞林注射液产权",
    "href": "http://stock.jrj.com.cn/2022/08/01191936860290.shtml",
    "datetime": "2022-08-01 19:19:46",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：宁波双成药品生产许可证变更",
    "href": "http://stock.jrj.com.cn/2022/07/12195936804547.shtml",
    "datetime": "2022-07-12 19:59:06",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：取得变更后的药品生产许可证",
    "href": "http://stock.jrj.com.cn/2022/06/21170936746631.shtml",
    "datetime": "2022-06-21 17:09:42",
    "code": "002693"
  },
  {
    "title": "5名高管齐抛减持计划 双成药业股价连续两日跌停",
    "href": "http://stock.jrj.com.cn/2022/05/18082836657338.shtml",
    "datetime": "2022-05-18 08:28:15",
    "code": "002693"
  },
  {
    "title": "双成药业：股票交易异常波动 无应披未披重大事项",
    "href": "http://stock.jrj.com.cn/2022/05/17190036656314.shtml",
    "datetime": "2022-05-17 19:00:45",
    "code": "002693"
  },
  {
    "title": "【龙虎榜】双成药业5月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/05/17180436655838.shtml",
    "datetime": "2022-05-17 18:04:51",
    "code": "002693"
  },
  {
    "title": "五高管齐减持股价“涨停潮”转“跌停潮” 双成药业2022年保壳意图明显",
    "href": "http://stock.jrj.com.cn/2022/05/17095236654529.shtml",
    "datetime": "2022-05-17 09:52:00",
    "code": "002693"
  },
  {
    "title": "【龙虎榜】双成药业5月16日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/05/16180636652068.shtml",
    "datetime": "2022-05-16 18:06:00",
    "code": "002693"
  },
  {
    "title": "双成药业：董事、高管拟减持公司股份，合计占总股本比例不超0.28%",
    "href": "http://stock.jrj.com.cn/2022/05/16104936650342.shtml",
    "datetime": "2022-05-16 10:49:04",
    "code": "002693"
  },
  {
    "title": "双成药业股价半个月涨幅约90%：总经理、财务总监、董秘等5高管拟集体减持",
    "href": "http://stock.jrj.com.cn/2022/05/16081236649701.shtml",
    "datetime": "2022-05-16 08:12:53",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)多名高管拟合计减持不超0.28%公司股份",
    "href": "http://stock.jrj.com.cn/2022/05/15180936649299.shtml",
    "datetime": "2022-05-15 18:09:05",
    "code": "002693"
  },
  {
    "title": "双成药业董事、高管拟减持公司股份",
    "href": "http://stock.jrj.com.cn/2022/05/15172436649253.shtml",
    "datetime": "2022-05-15 17:24:25",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：监事周云亲属短线交易及致歉",
    "href": "http://stock.jrj.com.cn/2022/05/13195336647724.shtml",
    "datetime": "2022-05-13 19:53:09",
    "code": "002693"
  },
  {
    "title": "【龙虎榜】双成药业5月13日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/05/13180836647234.shtml",
    "datetime": "2022-05-13 18:08:41",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：280万股限制性股票将解除限售上市流通",
    "href": "http://stock.jrj.com.cn/2022/05/10162036620640.shtml",
    "datetime": "2022-05-10 16:20:32",
    "code": "002693"
  },
  {
    "title": "A股异动 | 肝炎概念股再度大涨，双成药业录得五连板",
    "href": "http://stock.jrj.com.cn/2022/05/05111536567569.shtml",
    "datetime": "2022-05-05 11:15:42",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：依替巴肽注射液sANDA获得美国FDA上市许可",
    "href": "http://stock.jrj.com.cn/2022/04/21233536423328.shtml",
    "datetime": "2022-04-21 23:35:02",
    "code": "002693"
  },
  {
    "title": "双成药业2022年一季度预计净利55万-80万同比扭亏为盈 收到仿制药质量评价奖励",
    "href": "http://stock.jrj.com.cn/2022/04/14185236336603.shtml",
    "datetime": "2022-04-14 18:52:54",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)一季度预盈55万元-80万元",
    "href": "http://stock.jrj.com.cn/2022/04/14160836334925.shtml",
    "datetime": "2022-04-14 16:08:18",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)通过菲律宾GMP符合性检查",
    "href": "http://stock.jrj.com.cn/2022/04/12171336315839.shtml",
    "datetime": "2022-04-12 17:13:42",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)2021年度净亏损2032.51万元",
    "href": "http://stock.jrj.com.cn/2022/04/07180936268717.shtml",
    "datetime": "2022-04-07 18:09:03",
    "code": "002693"
  },
  {
    "title": "双成药业2021年亏损2032.51万同比亏损减少 资产处置收益增加",
    "href": "http://stock.jrj.com.cn/2022/03/29201036155618.shtml",
    "datetime": "2022-03-29 20:10:36",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)业绩快报：2021年度净亏损2032.51万元",
    "href": "http://stock.jrj.com.cn/2022/03/29165136148293.shtml",
    "datetime": "2022-03-29 16:51:26",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：累计收到政府补助共668.65万元",
    "href": "http://stock.jrj.com.cn/2022/02/18164234392310.shtml",
    "datetime": "2022-02-18 16:42:18",
    "code": "002693"
  },
  {
    "title": "【龙虎榜】双成药业1月20日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/20180534179283.shtml",
    "datetime": "2022-01-20 18:05:02",
    "code": "002693"
  },
  {
    "title": "A股异动 | 双成药业(002693.SZ)连续第二日大跌 2021年预亏超1200万元",
    "href": "http://stock.jrj.com.cn/2022/01/19110834173217.shtml",
    "datetime": "2022-01-19 11:08:53",
    "code": "002693"
  },
  {
    "title": "双成药业2021年预计亏损1200万-1800万同比亏损减少 境内销量稳步增长",
    "href": "http://stock.jrj.com.cn/2022/01/17203234166077.shtml",
    "datetime": "2022-01-17 20:32:58",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：预计2021年度净亏损1200万元–1800万元",
    "href": "http://stock.jrj.com.cn/2022/01/17171234165136.shtml",
    "datetime": "2022-01-17 17:12:08",
    "code": "002693"
  },
  {
    "title": "双成药业：拟将盐酸美金刚片知识产权授予百善药业",
    "href": "http://stock.jrj.com.cn/2022/01/06212234131130.shtml",
    "datetime": "2022-01-06 21:22:17",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：拟斥不超4600万元投建长效多肽制剂车间(第五制剂车间)项目",
    "href": "http://stock.jrj.com.cn/2021/12/24171034058277.shtml",
    "datetime": "2021-12-24 17:10:51",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：向绍兴市越城区卫生健康局捐赠2万支注射用胸腺法新",
    "href": "http://stock.jrj.com.cn/2021/12/20171434034989.shtml",
    "datetime": "2021-12-20 17:14:11",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：盐酸美金刚片获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2021/12/10181133995414.shtml",
    "datetime": "2021-12-10 18:11:09",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：控股子公司取得一项实用新型专利证书",
    "href": "http://stock.jrj.com.cn/2021/11/25221233920652.shtml",
    "datetime": "2021-11-25 22:12:40",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：子公司取得2项实用新型专利证书",
    "href": "http://stock.jrj.com.cn/2021/11/22160733903988.shtml",
    "datetime": "2021-11-22 16:07:43",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：注射用生长抑素已通过仿制药质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2021/11/11170233836743.shtml",
    "datetime": "2021-11-11 17:02:27",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：子公司近日取得4项实用新型专利证书",
    "href": "http://stock.jrj.com.cn/2021/11/10160533831847.shtml",
    "datetime": "2021-11-10 16:05:28",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：控股子公司取得一项发明专利证书",
    "href": "http://stock.jrj.com.cn/2021/11/01192533799388.shtml",
    "datetime": "2021-11-01 19:25:18",
    "code": "002693"
  },
  {
    "title": "继续亏损！双成药业今年前9月净亏损403.37万元",
    "href": "http://stock.jrj.com.cn/2021/10/26182633756037.shtml",
    "datetime": "2021-10-26 18:26:41",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)第三季度净亏损1003.05万元",
    "href": "http://stock.jrj.com.cn/2021/10/26174833755672.shtml",
    "datetime": "2021-10-26 17:48:49",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：生长抑素原料药获得CEP证书",
    "href": "http://stock.jrj.com.cn/2021/10/20163433722039.shtml",
    "datetime": "2021-10-20 16:34:07",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：控股股东质押4600万股",
    "href": "http://stock.jrj.com.cn/2021/10/19213333718300.shtml",
    "datetime": "2021-10-19 21:33:59",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)第三季度预亏800万至1200万元",
    "href": "http://stock.jrj.com.cn/2021/10/14165333691326.shtml",
    "datetime": "2021-10-14 16:53:26",
    "code": "002693"
  },
  {
    "title": "双成药业：依替巴肽注射液ANDA获得美国FDA上市许可",
    "href": "http://stock.jrj.com.cn/2021/09/09163833409877.shtml",
    "datetime": "2021-09-09 16:38:12",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：依替巴肽注射液ANDA获得美国FDA上市许可",
    "href": "http://stock.jrj.com.cn/2021/09/09162933409811.shtml",
    "datetime": "2021-09-09 16:29:00",
    "code": "002693"
  },
  {
    "title": "双成药业2021年半年度净利599.68万元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/08/30174733353287.shtml",
    "datetime": "2021-08-30 17:47:23",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：控股股东质押1950万股",
    "href": "http://stock.jrj.com.cn/2021/08/18220033276162.shtml",
    "datetime": "2021-08-18 22:00:27",
    "code": "002693"
  },
  {
    "title": "双成药业控股股东双成投资质押1950万股 用于融资担保",
    "href": "http://stock.jrj.com.cn/2021/08/18204833275810.shtml",
    "datetime": "2021-08-18 20:48:41",
    "code": "002693"
  },
  {
    "title": "双成药业2021年上半年净利599.68万同比扭亏为盈 产品销量增加",
    "href": "http://stock.jrj.com.cn/2021/07/30205933177036.shtml",
    "datetime": "2021-07-30 20:59:10",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)业绩快报：半年度净利润599.68万元",
    "href": "http://stock.jrj.com.cn/2021/07/30164133175697.shtml",
    "datetime": "2021-07-30 16:41:20",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：控股子公司取得换发的药品生产许可证",
    "href": "http://stock.jrj.com.cn/2021/07/21162333130177.shtml",
    "datetime": "2021-07-21 16:23:16",
    "code": "002693"
  },
  {
    "title": "双成药业2021年上半年预计净利500万-700万同比扭亏为盈 主营业务稳步发展",
    "href": "http://stock.jrj.com.cn/2021/07/14233733097431.shtml",
    "datetime": "2021-07-14 23:37:25",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：预计上半年净利500万元至700万元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/07/14165133095240.shtml",
    "datetime": "2021-07-14 16:51:20",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：注射用胸腺法新拟中标第五批国家组织药品集采",
    "href": "http://stock.jrj.com.cn/2021/06/23193532984529.shtml",
    "datetime": "2021-06-23 19:35:30",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：控股股东解除融资融券业务 涉及1100万股",
    "href": "http://stock.jrj.com.cn/2021/06/14180032926132.shtml",
    "datetime": "2021-06-14 18:00:41",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：公司药品生产许可证变更",
    "href": "http://stock.jrj.com.cn/2021/06/14175832926126.shtml",
    "datetime": "2021-06-14 17:58:41",
    "code": "002693"
  },
  {
    "title": "双成药业：公司没有产品在医美领域",
    "href": "http://stock.jrj.com.cn/2021/04/30140832486730.shtml",
    "datetime": "2021-04-30 14:08:22",
    "code": "002693"
  },
  {
    "title": "A股异动 | 双成药业(002693.SZ)涨近5% 依替巴肽注射液获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/04/26104732452634.shtml",
    "datetime": "2021-04-26 10:47:19",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：依替巴肽注射液获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/04/26080732451403.shtml",
    "datetime": "2021-04-26 08:07:55",
    "code": "002693"
  },
  {
    "title": "双成药业2020年亏损5332.94万 副董事长WangYingpu薪酬30.48万",
    "href": "http://stock.jrj.com.cn/2021/04/21152132416153.shtml",
    "datetime": "2021-04-21 15:21:08",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)2020年度业绩盈转亏至5332.94万元",
    "href": "http://stock.jrj.com.cn/2021/04/20201432411758.shtml",
    "datetime": "2021-04-20 20:14:45",
    "code": "002693"
  },
  {
    "title": "双成药业2021年第一季度预计亏损200万-400万 较上年同期亏损程度有所减少",
    "href": "http://stock.jrj.com.cn/2021/04/18095732392565.shtml",
    "datetime": "2021-04-18 09:57:46",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)一季度预亏200万元-400万元",
    "href": "http://stock.jrj.com.cn/2021/04/14172632372489.shtml",
    "datetime": "2021-04-14 17:26:21",
    "code": "002693"
  },
  {
    "title": "【龙虎榜】双成药业3月23日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/03/23180832202806.shtml",
    "datetime": "2021-03-23 18:08:34",
    "code": "002693"
  },
  {
    "title": "【龙虎榜】双成药业3月22日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/03/22180632195675.shtml",
    "datetime": "2021-03-22 18:06:15",
    "code": "002693"
  },
  {
    "title": "A股异动 | 双成药业(002693.SZ)涨停 向79名激励对象授予700万份股票期权",
    "href": "http://stock.jrj.com.cn/2021/03/19095432161938.shtml",
    "datetime": "2021-03-19 09:54:40",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)向79名激励对象授予700万份股票期权及8名激励对象授予700万股限制性股票",
    "href": "http://stock.jrj.com.cn/2021/03/18192532158784.shtml",
    "datetime": "2021-03-18 19:25:45",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：公司药品生产许可证变更 新增生产范围大容量注射剂",
    "href": "http://stock.jrj.com.cn/2021/03/16164432145480.shtml",
    "datetime": "2021-03-16 16:44:42",
    "code": "002693"
  },
  {
    "title": "双成药业控股股东双成投资质押1200万股 用于补充质押",
    "href": "http://stock.jrj.com.cn/2021/03/03195232065383.shtml",
    "datetime": "2021-03-03 19:52:08",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：控股股东补充质押1200万股",
    "href": "http://stock.jrj.com.cn/2021/03/03171032064230.shtml",
    "datetime": "2021-03-03 17:10:26",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：拟向激励对象授予股票权益合计不超1400万份",
    "href": "http://stock.jrj.com.cn/2021/03/02200732059092.shtml",
    "datetime": "2021-03-02 20:07:51",
    "code": "002693"
  },
  {
    "title": "双成药业2020年度亏损4902.95万由盈转亏 资产处置收益金额较大",
    "href": "http://stock.jrj.com.cn/2021/02/24190932020092.shtml",
    "datetime": "2021-02-24 19:09:21",
    "code": "002693"
  },
  {
    "title": "双成药业2020年预计亏损4200万-5800万由盈转亏 上年资产处置收益金额较大",
    "href": "http://stock.jrj.com.cn/2021/01/18194631716841.shtml",
    "datetime": "2021-01-18 19:46:33",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：2020年度预亏4200万元-5800万元",
    "href": "http://stock.jrj.com.cn/2021/01/18171431715989.shtml",
    "datetime": "2021-01-18 17:14:38",
    "code": "002693"
  },
  {
    "title": "双成药业2020年预计亏损4200万-5800万 较上年同期由盈转亏",
    "href": "http://stock.jrj.com.cn/2021/01/15193831700905.shtml",
    "datetime": "2021-01-15 19:38:58",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：2020年度预亏4200万元-5800万元",
    "href": "http://stock.jrj.com.cn/2021/01/15171031699839.shtml",
    "datetime": "2021-01-15 17:10:31",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：注射用比伐芦定通过注射剂质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2020/12/30162931605113.shtml",
    "datetime": "2020-12-30 16:29:20",
    "code": "002693"
  },
  {
    "title": "[双成药业]双成药业 注射用比伐芦定通过注射剂质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2020/12/30000031737540.shtml",
    "datetime": "2020-12-30 00:00:00",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：子公司宁波双成2020年底预计对固体制剂车间机器设备确认减值损失937.99万元",
    "href": "http://stock.jrj.com.cn/2020/12/28204531588331.shtml",
    "datetime": "2020-12-28 20:45:24",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：部分资产报废处置",
    "href": "http://stock.jrj.com.cn/2020/12/28204431588328.shtml",
    "datetime": "2020-12-28 20:44:23",
    "code": "002693"
  },
  {
    "title": "[双成药业]双成药业注射用胸腺法新通过 注射剂质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2020/12/21000031535836.shtml",
    "datetime": "2020-12-21 00:00:00",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：注射用胸腺法新通过注射剂质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2020/12/18173531519428.shtml",
    "datetime": "2020-12-18 17:35:28",
    "code": "002693"
  },
  {
    "title": "双成药业(002693.SZ)：被认定为海南省总部企业",
    "href": "http://stock.jrj.com.cn/2020/12/17172531510313.shtml",
    "datetime": "2020-12-17 17:25:50",
    "code": "002693"
  },
  {
    "title": "[双成药业]双成药业获批设立博士后工作站",
    "href": "http://stock.jrj.com.cn/2020/12/08000031438697.shtml",
    "datetime": "2020-12-08 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]中国工程院王红阳院士、杨宝峰院士、 及王锐院士一行莅临双成药业调研",
    "href": "http://stock.jrj.com.cn/2020/12/07000031432818.shtml",
    "datetime": "2020-12-07 00:00:00",
    "code": "002693"
  },
  {
    "title": "双成药业2020年前三季度亏损2567.53万 全资子公司维乐药业代理业务终止",
    "href": "http://stock.jrj.com.cn/2020/10/28095731149066.shtml",
    "datetime": "2020-10-28 09:57:07",
    "code": "002693"
  },
  {
    "title": "双成药业：2020年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/15082031057288.shtml",
    "datetime": "2020-10-15 08:20:02",
    "code": "002693"
  },
  {
    "title": "双成药业2020年前三季度亏损2200万至2800万 上年同期政府补助转入损益金额较大",
    "href": "http://stock.jrj.com.cn/2020/10/14190131053023.shtml",
    "datetime": "2020-10-14 19:01:35",
    "code": "002693"
  },
  {
    "title": "[双成药业]中国博士后科技服务团走进双成药业",
    "href": "http://stock.jrj.com.cn/2020/09/18000030798250.shtml",
    "datetime": "2020-09-18 00:00:00",
    "code": "002693"
  },
  {
    "title": "双成药业2020年上半年亏损1705.42万同比亏损增大 无代理业务收入",
    "href": "http://stock.jrj.com.cn/2020/08/20222630552055.shtml",
    "datetime": "2020-08-20 22:26:30",
    "code": "002693"
  },
  {
    "title": "双成药业2020年上半年亏损1705.42万亏损增长 部分产品销量下滑",
    "href": "http://stock.jrj.com.cn/2020/07/30211430387403.shtml",
    "datetime": "2020-07-30 21:14:43",
    "code": "002693"
  },
  {
    "title": "双成药业股东HSP质押1621万股 用于融资担保",
    "href": "http://stock.jrj.com.cn/2020/07/21194730306573.shtml",
    "datetime": "2020-07-21 19:47:53",
    "code": "002693"
  },
  {
    "title": "双成药业：2020年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/07/15084030245949.shtml",
    "datetime": "2020-07-15 08:40:08",
    "code": "002693"
  },
  {
    "title": "双成药业2020年上半年预计亏损1500万元-1800万元 较上年同期亏损增加",
    "href": "http://stock.jrj.com.cn/2020/07/14212630241532.shtml",
    "datetime": "2020-07-14 21:26:44",
    "code": "002693"
  },
  {
    "title": "双成药业签订《技术转让合同》 支付转让费3920万元",
    "href": "http://stock.jrj.com.cn/2020/06/08203329874001.shtml",
    "datetime": "2020-06-08 20:33:55",
    "code": "002693"
  },
  {
    "title": "双成药业：拟3920万元受让注射用紫杉醇项目的技术秘密",
    "href": "http://stock.jrj.com.cn/2020/06/08172429872699.shtml",
    "datetime": "2020-06-08 17:24:12",
    "code": "002693"
  },
  {
    "title": "双成药业2020年一季度亏损526.02万亏损减少 宁波双成受托加工收入减少",
    "href": "http://stock.jrj.com.cn/2020/04/30130629430105.shtml",
    "datetime": "2020-04-30 13:06:26",
    "code": "002693"
  },
  {
    "title": "双成药业2019年净利2465.64万元 较上年同期扭亏为盈",
    "href": "http://stock.jrj.com.cn/2020/04/29105029416996.shtml",
    "datetime": "2020-04-29 10:50:30",
    "code": "002693"
  },
  {
    "title": "双成药业：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/14023029278063.shtml",
    "datetime": "2020-04-14 02:30:00",
    "code": "002693"
  },
  {
    "title": "双成药业股东双成投资质押2315万股 用于融资担保",
    "href": "http://stock.jrj.com.cn/2020/04/06211929215844.shtml",
    "datetime": "2020-04-06 21:19:36",
    "code": "002693"
  },
  {
    "title": "双成药业：注射用比伐芦定出口美国首批产品出货",
    "href": "http://stock.jrj.com.cn/2020/03/18211929054838.shtml",
    "datetime": "2020-03-18 21:19:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]热烈庆祝双成药业注射用比伐芦定出口美国首批产品出货仪式隆重举行",
    "href": "http://stock.jrj.com.cn/2020/03/18000029053259.shtml",
    "datetime": "2020-03-18 00:00:00",
    "code": "002693"
  },
  {
    "title": "双成药业2019年度盈利2843万 政府补助项目通过验收",
    "href": "http://stock.jrj.com.cn/2020/02/27212028908997.shtml",
    "datetime": "2020-02-27 21:20:49",
    "code": "002693"
  },
  {
    "title": "[双成药业]防疫情、保市场,高新区生产企业在行动(五):双成药业",
    "href": "http://stock.jrj.com.cn/2020/02/17000028846945.shtml",
    "datetime": "2020-02-17 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]防疫情、保市场,高新区生产企业在行动(五):双成药业",
    "href": "http://stock.jrj.com.cn/2020/02/17000030647355.shtml",
    "datetime": "2020-02-17 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]海南农信社主动到海南双成药业了解疫情防控信贷需求",
    "href": "http://stock.jrj.com.cn/2020/02/10000030647358.shtml",
    "datetime": "2020-02-10 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]海南农信社主动到海南双成药业了解疫情防控信贷需求",
    "href": "http://stock.jrj.com.cn/2020/02/10000028846944.shtml",
    "datetime": "2020-02-10 00:00:00",
    "code": "002693"
  },
  {
    "title": "[赛隆药业]白衣天使出征注射胸腺法新 双成药业、安科生物、赛隆药业等公司生产",
    "href": "http://stock.jrj.com.cn/2020/02/08000031604858.shtml",
    "datetime": "2020-02-08 00:00:00",
    "code": "002693"
  },
  {
    "title": "双成药业：已捐赠1.54万支注射用胸腺法新支持抗击肺炎疫情",
    "href": "http://stock.jrj.com.cn/2020/02/07181628794284.shtml",
    "datetime": "2020-02-07 18:16:00",
    "code": "002693"
  },
  {
    "title": "白衣天使出征注射胸腺法新 双成药业、安科生物等公司生产",
    "href": "http://stock.jrj.com.cn/2020/02/07112328792091.shtml",
    "datetime": "2020-02-07 11:23:00",
    "code": "002693"
  },
  {
    "title": "双成药业 ：2019年业绩扭亏为盈 预计实现归母净利润1900万元至2800万元",
    "href": "http://stock.jrj.com.cn/2020/02/05224228778552.shtml",
    "datetime": "2020-02-05 22:42:44",
    "code": "002693"
  },
  {
    "title": "[双成药业]双成药业! 不忘初心!让爱传递!为战斗在疫情第一线的医务人员保驾护航!",
    "href": "http://stock.jrj.com.cn/2020/02/05000028777231.shtml",
    "datetime": "2020-02-05 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]双成药业! 不忘初心!让爱传递!为战斗在疫情第一线的医务人员保驾护航!",
    "href": "http://stock.jrj.com.cn/2020/02/05000030647356.shtml",
    "datetime": "2020-02-05 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]双成药业致敬\"最美逆行者\"!捐赠海南医学院第一附属医院援武汉医疗队 注射用胸腺法新,我们在行动!",
    "href": "http://stock.jrj.com.cn/2020/02/05000030647359.shtml",
    "datetime": "2020-02-05 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]双成药业致敬\"最美逆行者\"!捐赠海南医学院第一附属医院援武汉医疗队 注射用胸腺法新,我们在行动!",
    "href": "http://stock.jrj.com.cn/2020/02/05000028777234.shtml",
    "datetime": "2020-02-05 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]关于《海口市秀英区生态环境局责令限制生产决定书》 (秀环限字【2020】1号)的整改方案",
    "href": "http://stock.jrj.com.cn/2020/01/21000030647360.shtml",
    "datetime": "2020-01-21 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]关于《海口市秀英区生态环境局责令限制生产决定书》 (秀环限字【2020】1号)的整改方案",
    "href": "http://stock.jrj.com.cn/2020/01/21000028750099.shtml",
    "datetime": "2020-01-21 00:00:00",
    "code": "002693"
  },
  {
    "title": "双成药业2019年扭亏为盈 预计净利1900万元至2800万元",
    "href": "http://stock.jrj.com.cn/2020/01/20182428707035.shtml",
    "datetime": "2020-01-20 18:24:54",
    "code": "002693"
  },
  {
    "title": "双成药业 ：2019年业绩扭亏为盈 预计实现归母净利润1900万元至2800万元",
    "href": "http://stock.jrj.com.cn/2020/01/20174128706788.shtml",
    "datetime": "2020-01-20 17:41:25",
    "code": "002693"
  },
  {
    "title": "双成药业：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/20173028706731.shtml",
    "datetime": "2020-01-20 17:30:00",
    "code": "002693"
  },
  {
    "title": "双成药业使用1500万元自有资金购买理财产品",
    "href": "http://stock.jrj.com.cn/2020/01/09214828651969.shtml",
    "datetime": "2020-01-09 21:48:07",
    "code": "002693"
  },
  {
    "title": "[双成药业]海南双成药业控股子公司宁波双成通过美国FDA现场检查",
    "href": "http://stock.jrj.com.cn/2019/12/17000030102548.shtml",
    "datetime": "2019-12-17 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]海南双成药业控股子公司宁波双成通过美国FDA现场检查",
    "href": "http://stock.jrj.com.cn/2019/12/17000028569568.shtml",
    "datetime": "2019-12-17 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]双成药业总经理李建明博士出席第五届多肽药物研发及规模化生产前沿技术学术交流会",
    "href": "http://stock.jrj.com.cn/2019/11/15000028422691.shtml",
    "datetime": "2019-11-15 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]双成药业总经理李建明博士出席第五届多肽药物研发及规模化生产前沿技术学术交流会",
    "href": "http://stock.jrj.com.cn/2019/11/15000029999969.shtml",
    "datetime": "2019-11-15 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]双成药业总经理李建明博士出席海南医药行业国际化认证标准培训",
    "href": "http://stock.jrj.com.cn/2019/11/08000028369939.shtml",
    "datetime": "2019-11-08 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]双成药业总经理李建明博士出席海南医药行业国际化认证标准培训",
    "href": "http://stock.jrj.com.cn/2019/11/08000030003335.shtml",
    "datetime": "2019-11-08 00:00:00",
    "code": "002693"
  },
  {
    "title": "双成药业第三季度盈利亏损707.33万 同比增长48.16%",
    "href": "http://stock.jrj.com.cn/2019/10/30170928326426.shtml",
    "datetime": "2019-10-30 17:09:57",
    "code": "002693"
  },
  {
    "title": "双成药业：注射用比伐芦定获美国FDA仿制药上市批准",
    "href": "http://stock.jrj.com.cn/2019/10/24175628294966.shtml",
    "datetime": "2019-10-24 17:56:52",
    "code": "002693"
  },
  {
    "title": "双成药业：注射用比伐芦定获得美国FDA仿制药上市批准",
    "href": "http://stock.jrj.com.cn/2019/10/24175428294941.shtml",
    "datetime": "2019-10-24 17:54:02",
    "code": "002693"
  },
  {
    "title": "[双成药业]双成药业注射用比伐芦定获得美国FDA仿制药上市最终批准",
    "href": "http://stock.jrj.com.cn/2019/10/24000030003334.shtml",
    "datetime": "2019-10-24 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]双成药业注射用比伐芦定获得美国FDA仿制药上市最终批准",
    "href": "http://stock.jrj.com.cn/2019/10/24000028369938.shtml",
    "datetime": "2019-10-24 00:00:00",
    "code": "002693"
  },
  {
    "title": "双成药业2019年前三季度净利亏损1900万-2300万 验收补助收入转入当期损益",
    "href": "http://stock.jrj.com.cn/2019/10/15103928248854.shtml",
    "datetime": "2019-10-15 10:39:37",
    "code": "002693"
  },
  {
    "title": "承担的国家科技重大专项项目已通过验收 双成药业涨停",
    "href": "http://stock.jrj.com.cn/2019/09/25095828176625.shtml",
    "datetime": "2019-09-25 09:58:13",
    "code": "002693"
  },
  {
    "title": "双成药业承担的国家科技重大专项项目通过验收",
    "href": "http://stock.jrj.com.cn/2019/09/24180428173681.shtml",
    "datetime": "2019-09-24 18:04:18",
    "code": "002693"
  },
  {
    "title": "双成药业：公司承担的国家科技重大专项项目已通过验收",
    "href": "http://stock.jrj.com.cn/2019/09/24175928173646.shtml",
    "datetime": "2019-09-24 17:59:36",
    "code": "002693"
  },
  {
    "title": "双成药业：公司承担的国家科技重大专项项目通过验收",
    "href": "http://stock.jrj.com.cn/2019/09/24173828173546.shtml",
    "datetime": "2019-09-24 17:38:00",
    "code": "002693"
  },
  {
    "title": "双成药业子公司维乐药业与铨福发展终止《总经销协议书》",
    "href": "http://stock.jrj.com.cn/2019/08/16093227985730.shtml",
    "datetime": "2019-08-16 09:32:37",
    "code": "002693"
  },
  {
    "title": "双成药业全资子公司日常经营重大合同终止执行",
    "href": "http://stock.jrj.com.cn/2019/08/16083927985472.shtml",
    "datetime": "2019-08-16 08:39:35",
    "code": "002693"
  },
  {
    "title": "双成药业2019年上半年亏损1456万 加强人力成本控制",
    "href": "http://stock.jrj.com.cn/2019/08/15173627982187.shtml",
    "datetime": "2019-08-15 17:36:54",
    "code": "002693"
  },
  {
    "title": "双成药业全资子公司获得《药品经营许可证》和《药品GSP认证证书》",
    "href": "http://stock.jrj.com.cn/2019/08/07224927944419.shtml",
    "datetime": "2019-08-07 22:49:01",
    "code": "002693"
  },
  {
    "title": "双成药业股东股份解除质押2450万股",
    "href": "http://stock.jrj.com.cn/2019/08/06074727935159.shtml",
    "datetime": "2019-08-06 07:47:09",
    "code": "002693"
  },
  {
    "title": "双成药业2019年上半年亏损1456万 政府补助增加",
    "href": "http://stock.jrj.com.cn/2019/07/30175727904729.shtml",
    "datetime": "2019-07-30 17:57:31",
    "code": "002693"
  },
  {
    "title": "双成药业签订技术转让合同 花费1920万受让两项专有技术",
    "href": "http://stock.jrj.com.cn/2019/07/18142627857186.shtml",
    "datetime": "2019-07-18 14:26:19",
    "code": "002693"
  },
  {
    "title": "[双成药业]海南双成药业股份有限公司通过美国FDA现场检查",
    "href": "http://stock.jrj.com.cn/2019/07/01000028063747.shtml",
    "datetime": "2019-07-01 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]热烈祝贺海南双成药业股份有限公司注射用比伐芦定专利挑战成功",
    "href": "http://stock.jrj.com.cn/2019/06/24000027748399.shtml",
    "datetime": "2019-06-24 00:00:00",
    "code": "002693"
  },
  {
    "title": "双成药业增收不增利 销售费1.8亿研发费仅2048万",
    "href": "http://stock.jrj.com.cn/2019/05/10081427552145.shtml",
    "datetime": "2019-05-10 08:14:10",
    "code": "002693"
  },
  {
    "title": "扣非净利连亏3年 昔日多肽药龙头双成药业怎么了",
    "href": "http://stock.jrj.com.cn/2019/05/09011227544873.shtml",
    "datetime": "2019-05-09 01:12:38",
    "code": "002693"
  },
  {
    "title": "收入翻倍但扣非净利连亏三年 昔日多肽药龙头双成药业怎么了？",
    "href": "http://stock.jrj.com.cn/2019/05/08013327539433.shtml",
    "datetime": "2019-05-08 01:33:42",
    "code": "002693"
  },
  {
    "title": "早间公告：华仁药业控股股东筹划股权转让 双成药业在美国发起专利挑战",
    "href": "http://stock.jrj.com.cn/2019/05/06081727527167.shtml",
    "datetime": "2019-05-06 08:17:00",
    "code": "002693"
  },
  {
    "title": "双成药业一季度亏损888万较上年同期亏损增加 现金流量净额1776万",
    "href": "http://stock.jrj.com.cn/2019/05/06070627526827.shtml",
    "datetime": "2019-05-06 07:06:45",
    "code": "002693"
  },
  {
    "title": "双成药业去年营收3.37亿元 同比增长37% 董事长王成栋年薪60万元",
    "href": "http://stock.jrj.com.cn/2019/04/19063827426207.shtml",
    "datetime": "2019-04-19 06:38:41",
    "code": "002693"
  },
  {
    "title": "双成药业：2018年亏损6946万元",
    "href": "http://stock.jrj.com.cn/2019/04/18171927423200.shtml",
    "datetime": "2019-04-18 17:19:00",
    "code": "002693"
  },
  {
    "title": "海南板块拉升 海南高速、双成药业涨停",
    "href": "http://stock.jrj.com.cn/2019/04/09103027353042.shtml",
    "datetime": "2019-04-09 10:30:00",
    "code": "002693"
  },
  {
    "title": "双成药业2018年亏损6914万元 自产药品销售费用增幅过大",
    "href": "http://stock.jrj.com.cn/2019/02/26074327090092.shtml",
    "datetime": "2019-02-26 07:43:42",
    "code": "002693"
  },
  {
    "title": "双成药业股东HSP质押2450万股 其持有的38%被质押",
    "href": "http://stock.jrj.com.cn/2019/02/20221027068215.shtml",
    "datetime": "2019-02-20 22:10:37",
    "code": "002693"
  },
  {
    "title": "[双成药业]海南双成药业股份有限公司2018年年会",
    "href": "http://stock.jrj.com.cn/2019/01/29000027911411.shtml",
    "datetime": "2019-01-29 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]海南双成药业股份有限公司2018年年会",
    "href": "http://stock.jrj.com.cn/2019/01/29000026996773.shtml",
    "datetime": "2019-01-29 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]关于注射用比伐芦定获得国家药监局批件的公告",
    "href": "http://stock.jrj.com.cn/2019/01/29000026997838.shtml",
    "datetime": "2019-01-29 00:00:00",
    "code": "002693"
  },
  {
    "title": "双成药业：注射用比伐芦定获得国家药监局批件",
    "href": "http://stock.jrj.com.cn/2019/01/28164326992308.shtml",
    "datetime": "2019-01-28 16:43:00",
    "code": "002693"
  },
  {
    "title": "双成药业：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/26000025260846.shtml",
    "datetime": "2018-10-26 00:00:00",
    "code": "002693"
  },
  {
    "title": "双成药业证券事务代表李志莹辞职",
    "href": "http://stock.jrj.com.cn/2018/10/10104325180779.shtml",
    "datetime": "2018-10-10 10:43:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]热烈祝贺双成药业获得2018海口国家高新区“工会",
    "href": "http://stock.jrj.com.cn/2018/07/11000025031627.shtml",
    "datetime": "2018-07-11 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]关于注射用比伐芦定 ANDA 获得美国 FDA 暂定批准",
    "href": "http://stock.jrj.com.cn/2018/06/08000025031626.shtml",
    "datetime": "2018-06-08 00:00:00",
    "code": "002693"
  },
  {
    "title": "海南板块表现强劲 新大洲A强势涨停",
    "href": "http://stock.jrj.com.cn/2018/06/04093324632922.shtml",
    "datetime": "2018-06-04 09:33:27",
    "code": "002693"
  },
  {
    "title": "双成药业注射用比伐芦定ANDA获美国FDA暂定批准",
    "href": "http://stock.jrj.com.cn/2018/06/04010824630851.shtml",
    "datetime": "2018-06-04 01:08:39",
    "code": "002693"
  },
  {
    "title": "双成药业：注射用比伐芦定ANDA获美国FDA暂定批准",
    "href": "http://stock.jrj.com.cn/2018/06/03183524630346.shtml",
    "datetime": "2018-06-03 18:35:00",
    "code": "002693"
  },
  {
    "title": "海南板块持续走强 罗牛山、双成药业涨停",
    "href": "http://stock.jrj.com.cn/2018/05/16103624546940.shtml",
    "datetime": "2018-05-16 10:36:23",
    "code": "002693"
  },
  {
    "title": "医药股再度集体走强 双成药业、常山药业等涨停",
    "href": "http://stock.jrj.com.cn/2018/05/16103524546927.shtml",
    "datetime": "2018-05-16 10:35:00",
    "code": "002693"
  },
  {
    "title": "海南板块“枯木逢春” 双成药业强势涨停",
    "href": "http://stock.jrj.com.cn/2018/05/16101024546777.shtml",
    "datetime": "2018-05-16 10:10:08",
    "code": "002693"
  },
  {
    "title": "[双成药业]过一致性评价品种招采遇阻,高质量仿制药还得",
    "href": "http://stock.jrj.com.cn/2018/05/10000025031621.shtml",
    "datetime": "2018-05-10 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]市场呼吁好药 勿让“劣币”驱逐“良币”",
    "href": "http://stock.jrj.com.cn/2018/05/07000025031618.shtml",
    "datetime": "2018-05-07 00:00:00",
    "code": "002693"
  },
  {
    "title": "双成药业：部分产品将于2018年向美国FDA申报",
    "href": "http://stock.jrj.com.cn/2018/04/27145024465289.shtml",
    "datetime": "2018-04-27 14:50:00",
    "code": "002693"
  },
  {
    "title": "双成药业：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/04/26183024458098.shtml",
    "datetime": "2018-04-26 18:30:00",
    "code": "002693"
  },
  {
    "title": "双成药业：2018年第一季度业绩报告预告(修正公告)",
    "href": "http://stock.jrj.com.cn/2018/04/12180024381984.shtml",
    "datetime": "2018-04-12 18:00:00",
    "code": "002693"
  },
  {
    "title": "双成药业下修年度业绩快报",
    "href": "http://stock.jrj.com.cn/2018/04/12173024381871.shtml",
    "datetime": "2018-04-12 17:30:00",
    "code": "002693"
  },
  {
    "title": "卫星导航板块继续昨日强势 华测导航移为通信两连板",
    "href": "http://stock.jrj.com.cn/2018/04/10093624366510.shtml",
    "datetime": "2018-04-10 09:36:41",
    "code": "002693"
  },
  {
    "title": "习近平主席将发表主旨演讲 海南板块连续第三天高开",
    "href": "http://stock.jrj.com.cn/2018/04/10093024366441.shtml",
    "datetime": "2018-04-10 09:30:43",
    "code": "002693"
  },
  {
    "title": "医药+海南 双成药业实现四连板",
    "href": "http://stock.jrj.com.cn/2018/04/09100024360745.shtml",
    "datetime": "2018-04-09 10:00:52",
    "code": "002693"
  },
  {
    "title": "博鳌亚洲论坛开幕 海南板块3股一字板",
    "href": "http://stock.jrj.com.cn/2018/04/09095324360685.shtml",
    "datetime": "2018-04-09 09:53:05",
    "code": "002693"
  },
  {
    "title": "海南板块开盘大涨 双成药业开盘涨停实现四连板",
    "href": "http://stock.jrj.com.cn/2018/04/09094624360631.shtml",
    "datetime": "2018-04-09 09:46:13",
    "code": "002693"
  },
  {
    "title": "海南板块大涨 双成药业等4股涨停",
    "href": "http://stock.jrj.com.cn/2018/04/09092924360482.shtml",
    "datetime": "2018-04-09 09:29:20",
    "code": "002693"
  },
  {
    "title": "医药板块强势领跑两市 双成药业实现三连板",
    "href": "http://stock.jrj.com.cn/2018/04/04095224349559.shtml",
    "datetime": "2018-04-04 09:52:26",
    "code": "002693"
  },
  {
    "title": "医药板块走强 双成药业秒板",
    "href": "http://stock.jrj.com.cn/2018/04/03105124343613.shtml",
    "datetime": "2018-04-03 10:51:33",
    "code": "002693"
  },
  {
    "title": "快讯：海南板块早盘大幅拉升 双成药业快速涨停",
    "href": "http://stock.jrj.com.cn/2018/04/02095024336751.shtml",
    "datetime": "2018-04-02 09:50:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]滔罗特江苏市场首站告捷!",
    "href": "http://stock.jrj.com.cn/2018/03/06000025031615.shtml",
    "datetime": "2018-03-06 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]2017年度滔罗特菁英代理商年会圆满结束!",
    "href": "http://stock.jrj.com.cn/2018/01/26000025031614.shtml",
    "datetime": "2018-01-26 00:00:00",
    "code": "002693"
  },
  {
    "title": "经营业绩未达预期 双成药业拟2.6亿抛澳亚生物46%股权",
    "href": "http://stock.jrj.com.cn/2017/12/25224923848959.shtml",
    "datetime": "2017-12-25 22:49:09",
    "code": "002693"
  },
  {
    "title": "双成药业：拟2.6亿元转让澳亚生物46%股权",
    "href": "http://stock.jrj.com.cn/2017/12/24163023843288.shtml",
    "datetime": "2017-12-24 16:30:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]关于公司总经理职位变动的公告",
    "href": "http://stock.jrj.com.cn/2017/12/06000025031619.shtml",
    "datetime": "2017-12-06 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]关于公司副总经理职位变动的公告",
    "href": "http://stock.jrj.com.cn/2017/12/06000025031624.shtml",
    "datetime": "2017-12-06 00:00:00",
    "code": "002693"
  },
  {
    "title": "前海旗隆列入行业协会失联名单 双成药业关联方曾联手搞并购",
    "href": "http://stock.jrj.com.cn/2017/12/03205823732867.shtml",
    "datetime": "2017-12-03 20:58:13",
    "code": "002693"
  },
  {
    "title": "[双成药业]总局关于调整原料药、药用辅料和药包材审评审",
    "href": "http://stock.jrj.com.cn/2017/12/01000025031639.shtml",
    "datetime": "2017-12-01 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]中国自主品牌峰会健康中国专题研讨会在京召开",
    "href": "http://stock.jrj.com.cn/2017/11/23000025031633.shtml",
    "datetime": "2017-11-23 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]总局关于调整药品注册受理工作的公告(2017年第",
    "href": "http://stock.jrj.com.cn/2017/11/15000025031628.shtml",
    "datetime": "2017-11-15 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]依替巴肽DMF通过美国FDA完整性审评",
    "href": "http://stock.jrj.com.cn/2017/11/02000025031617.shtml",
    "datetime": "2017-11-02 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]海南双成药业股份有限公司收到美国FDA GMP检查报",
    "href": "http://stock.jrj.com.cn/2017/09/25000025031610.shtml",
    "datetime": "2017-09-25 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]总局关于发布《仿制药质量和疗效一致性评价受",
    "href": "http://stock.jrj.com.cn/2017/09/06000025031609.shtml",
    "datetime": "2017-09-06 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]总局关于仿制药质量和疗效一致性评价工作有关",
    "href": "http://stock.jrj.com.cn/2017/08/25000025031608.shtml",
    "datetime": "2017-08-25 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]什么是生物等效性",
    "href": "http://stock.jrj.com.cn/2017/07/26000025031612.shtml",
    "datetime": "2017-07-26 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]使用基泰后多长时间可以起效",
    "href": "http://stock.jrj.com.cn/2017/07/26000025031611.shtml",
    "datetime": "2017-07-26 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]基泰与化疗联合应用有哪些好处",
    "href": "http://stock.jrj.com.cn/2017/07/26000025031629.shtml",
    "datetime": "2017-07-26 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]基泰(注射用胸腺肽α1)说明",
    "href": "http://stock.jrj.com.cn/2017/07/26000025031623.shtml",
    "datetime": "2017-07-26 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]基泰用于治疗重症感染的原理是什么",
    "href": "http://stock.jrj.com.cn/2017/07/26000025031632.shtml",
    "datetime": "2017-07-26 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]基泰可以应用于血液病的治疗吗",
    "href": "http://stock.jrj.com.cn/2017/07/26000025031634.shtml",
    "datetime": "2017-07-26 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]基泰治疗难治性贫血的疗效如何",
    "href": "http://stock.jrj.com.cn/2017/07/26000025031638.shtml",
    "datetime": "2017-07-26 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]为什么说基泰是“进口药的品质,国产药的价格",
    "href": "http://stock.jrj.com.cn/2017/07/26000025031607.shtml",
    "datetime": "2017-07-26 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]如何理解基泰宜皮下注射,而不应做静脉注射或",
    "href": "http://stock.jrj.com.cn/2017/07/26000025031616.shtml",
    "datetime": "2017-07-26 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]胸腺肽α1治疗各型肿瘤和重症感染的给药方案是",
    "href": "http://stock.jrj.com.cn/2017/07/26000025031625.shtml",
    "datetime": "2017-07-26 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]基泰治疗恶性黑色素瘤的疗效如何",
    "href": "http://stock.jrj.com.cn/2017/07/26000025031630.shtml",
    "datetime": "2017-07-26 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]胸腺肽α1治疗成人白血病的效果如何",
    "href": "http://stock.jrj.com.cn/2017/07/26000025031637.shtml",
    "datetime": "2017-07-26 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]基泰对糖尿病人是否有降糖作用",
    "href": "http://stock.jrj.com.cn/2017/07/26000025031620.shtml",
    "datetime": "2017-07-26 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]基泰用于治疗晚期乳腺癌的效果如何",
    "href": "http://stock.jrj.com.cn/2017/07/26000025031635.shtml",
    "datetime": "2017-07-26 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]为什么胸腺肽α1没有在临床得到普遍应用",
    "href": "http://stock.jrj.com.cn/2017/07/26000025031613.shtml",
    "datetime": "2017-07-26 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]对于老年恶性肿瘤患者,应用基泰效果如何",
    "href": "http://stock.jrj.com.cn/2017/07/26000025031631.shtml",
    "datetime": "2017-07-26 00:00:00",
    "code": "002693"
  },
  {
    "title": "[双成药业]基泰可以用于恶性血液病干细胞移植吗",
    "href": "http://stock.jrj.com.cn/2017/07/26000025031636.shtml",
    "datetime": "2017-07-26 00:00:00",
    "code": "002693"
  },
  {
    "title": "[哈药股份]双成药业并购标的大演财务“洗澡”技",
    "href": "http://stock.jrj.com.cn/2017/01/22000024834589.shtml",
    "datetime": "2017-01-22 00:00:00",
    "code": "002693"
  },
  {
    "title": "双成药业下调中报业绩 预亏至多2000万元",
    "href": "http://stock.jrj.com.cn/2016/06/23171221106456.shtml",
    "datetime": "2016-06-23 17:12:16",
    "code": "002693"
  },
  {
    "title": "双成药业外延转型遇阻",
    "href": "http://stock.jrj.com.cn/2016/02/16005220558228.shtml",
    "datetime": "2016-02-16 00:52:36",
    "code": "002693"
  },
  {
    "title": "双成药业终止定增及资产收购",
    "href": "http://stock.jrj.com.cn/2016/02/14173920552121.shtml",
    "datetime": "2016-02-14 17:39:04",
    "code": "002693"
  },
  {
    "title": "双成药业终止股权转让协议",
    "href": "http://stock.jrj.com.cn/2016/02/14172520552118.shtml",
    "datetime": "2016-02-14 17:25:59",
    "code": "002693"
  },
  {
    "title": "双成药业获食药监局颁发药品GMP证书",
    "href": "http://stock.jrj.com.cn/2015/09/22162419849249.shtml",
    "datetime": "2015-09-22 16:24:42",
    "code": "002693"
  },
  {
    "title": "双成药业拟收购全国最大冻干粉针CMO",
    "href": "http://stock.jrj.com.cn/2015/02/03033618807123.shtml",
    "datetime": "2015-02-03 03:36:47",
    "code": "002693"
  },
  {
    "title": "双成药业:关于筹划非公开发行股票继续停牌的公告",
    "href": "http://stock.jrj.com.cn/2015/01/25231018761841.shtml",
    "datetime": "2015-01-25 23:10:59",
    "code": "002693"
  },
  {
    "title": "双成药业拟推1080万份股权激励 8日复牌",
    "href": "http://stock.jrj.com.cn/2014/12/08032418488239.shtml",
    "datetime": "2014-12-08 03:24:21",
    "code": "002693"
  },
  {
    "title": "双成药业终止资产收购 明起复牌",
    "href": "http://stock.jrj.com.cn/2014/01/16193916522362.shtml",
    "datetime": "2014-01-16 19:39:00",
    "code": "002693"
  },
  {
    "title": "双成药业控股股东筹划相关重大事项 10日起停牌",
    "href": "http://stock.jrj.com.cn/2014/01/09191316477921.shtml",
    "datetime": "2014-01-09 19:13:00",
    "code": "002693"
  },
  {
    "title": "双成药业转让“中华肝灵片”生产技术",
    "href": "http://stock.jrj.com.cn/2013/12/24120316384805.shtml",
    "datetime": "2013-12-24 12:03:00",
    "code": "002693"
  },
  {
    "title": "双成药业通过美国食品药监局认证",
    "href": "http://stock.jrj.com.cn/2013/12/04165716273810.shtml",
    "datetime": "2013-12-04 16:57:00",
    "code": "002693"
  },
  {
    "title": "双成药业2012分配拟10转5派3.5元",
    "href": "http://stock.jrj.com.cn/2013/02/28191615097996.shtml",
    "datetime": "2013-02-28 19:16:23",
    "code": "002693"
  },
  {
    "title": "双成药业收到254万元政府奖励",
    "href": "http://stock.jrj.com.cn/2012/11/12165114661710.shtml",
    "datetime": "2012-11-12 16:51:20",
    "code": "002693"
  },
  {
    "title": "双成药业：股东大会通过2.5亿元购买银行理财产品的",
    "href": "http://stock.jrj.com.cn/hotstock/2012/10/31080514598088.shtml",
    "datetime": "2012-10-31 08:05:02",
    "code": "002693"
  },
  {
    "title": "一拖股份、双成药业、远程电缆3股涨停",
    "href": "http://stock.jrj.com.cn/invest/2012/08/09143414069677.shtml",
    "datetime": "2012-08-09 14:34:36",
    "code": "002693"
  },
  {
    "title": "双成药业上市首日 涨幅逾三成",
    "href": "http://stock.jrj.com.cn/ipo/2012/08/09073514063046.shtml",
    "datetime": "2012-08-09 07:35:17",
    "code": "002693"
  },
  {
    "title": "午评：三新股上市表现不一 N一拖大涨N远程破发",
    "href": "http://stock.jrj.com.cn/ipo/2012/08/08113314054057.shtml",
    "datetime": "2012-08-08 11:33:42",
    "code": "002693"
  },
  {
    "title": "一拖股份等三新股今日上市 身价几何？",
    "href": "http://stock.jrj.com.cn/ipo/2012/08/08072714049700.shtml",
    "datetime": "2012-08-08 07:27:00",
    "code": "002693"
  },
  {
    "title": "一拖股份等三新股8月8日上市定位分析",
    "href": "http://stock.jrj.com.cn/ipo/2012/08/08064414048233.shtml",
    "datetime": "2012-08-08 06:44:45",
    "code": "002693"
  },
  {
    "title": "双成药业7月31日申购指南",
    "href": "http://stock.jrj.com.cn/ipo/2012/07/31063813964377.shtml",
    "datetime": "2012-07-31 06:38:19",
    "code": "002693"
  },
  {
    "title": "新股双成药业7月31日申购指南",
    "href": "http://stock.jrj.com.cn/ipo/2012/07/30143613958644.shtml",
    "datetime": "2012-07-30 14:36:00",
    "code": "002693"
  },
  {
    "title": "双成药业：拟发行3000万股 31日申购",
    "href": "http://stock.jrj.com.cn/ipo/2012/07/23195013888392.shtml",
    "datetime": "2012-07-23 19:50:12",
    "code": "002693"
  },
  {
    "title": "双成药业：被一群资本玩家控制的企业",
    "href": "http://stock.jrj.com.cn/ipo/2012/07/16104913806897.shtml",
    "datetime": "2012-07-16 10:49:55",
    "code": "002693"
  },
  {
    "title": "双成药业25日上会 拟发行3000万股",
    "href": "http://stock.jrj.com.cn/ipo/2012/04/22025912850741.shtml",
    "datetime": "2012-04-22 02:59:00",
    "code": "002693"
  },
  {
    "title": "双成药业25日上会 拟发3000万股",
    "href": "http://stock.jrj.com.cn/ipo/2012/04/20205812850742.shtml",
    "datetime": "2012-04-20 20:58:00",
    "code": "002693"
  },
  {
    "title": "双成药业预披露招股书 拟发3000万股",
    "href": "http://stock.jrj.com.cn/ipo/2012/03/16210912510687.shtml",
    "datetime": "2012-03-16 21:09:58",
    "code": "002693"
  }
]